Preetika Rana is an award-winning reporter for The Wall Street Journal in San Francisco with experience reporting from six ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

The screening used a diagnostic test developed by Florian ... has so far generated around a dozen antibody candidates that could be used as therapy for COVID-19, all targeting the S1 subunit ...

A monoclonal antibody treatment called Pemgarda has ... What should I do if I test positive for COVID-19? If you feel sick, stay home and away from others until 24 hours after you are fever ...

Better diagnostics, more focused treatment, and deeper understanding of individualized symptoms could all take major steps ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...

Hard on the heels of Regeneron moving its COVID-19 antibody cocktail into late-stage testing, the US government has agreed a deal to ramp up manufacturing – and claim the first doses to be made.

Vermont has the second lowest state fatality rate in the US (146.9 per 100K; Hawaii 112.8/100K). Mississippi (464.2/100K) and ...

The COVID-19 pandemic caused a significant shift in our daily routines, and virus testing procedures were not left untouched. The growing demand for testing sparked an increase in the use of at ...

Today, we face a new pandemic: misinformation. Addressing it requires continuous engagement – and not just from doctors.

Testing the vaccine in ... throughout the evolution of the new coronavirus, which gave the new variants more efficiency against neutralizing antibodies. The N protein, on the other hand, is ...